A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias

@article{Park1998ACS,
  title={A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias},
  author={WS Park and Y Bae and D Chung and T Kim and E Choi and J. W. Chung and M Lee and S J Park and M S Park and S Park},
  journal={Leukemia},
  year={1998},
  volume={12},
  pages={1583-1590}
}
We previously reported a novel differentiation antigen, which is specifically expressed in stage II double positive (CD4+CD8+) human cortical thymocytes (Park et al, J Exp Med 1993; 178: 1447–1451). This study was designed to investigate the expression pattern of JL1 in various types of leukemic cells from patients and normal hematopoietic cells to evaluate the possibility as a tool for diagnosis and treatment of leukemia. The expression of JL1 antigen was observed in 75.6% of leukemic cases… CONTINUE READING